Skip to main content
. Author manuscript; available in PMC: 2017 May 26.
Published in final edited form as: Bone Marrow Transplant. 2009 Jul 20;45(3):587–589. doi: 10.1038/bmt.2009.170

Figure 2.

Figure 2

B-lymphocyte (CD3–CD19 +) and NK cell (CD3–CD56 +) recovery over 2 years for patients who received unmodified marrow grafts (black lines and filled circles) vs patients who received grafts depleted of T cells using T10B9-A1.31 +complement (dashed lines and open triangles) or grafts processed by elutriation (dashed lines and filled squares). Horizontal lines represent the upper and lower normal range. B-cell absolute count reached the lower normal range at ~6 months for both groups and recovery did not differ between groups at any time point post-BMT. The NK cell absolute count was within the normal range at the first measurement period for both groups. NK recovery was significantly more robust in patients who received αβTCD grafts for the initial 12 months post-BMT but did not exceed the upper normal range.